Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB
THC
agonist bias
cannabinoid CB2 receptor
cell signaling
synthetic cannabinoid receptor agonist
Journal
Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
06
11
2023
accepted:
10
11
2023
medline:
30
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
ppublish
Résumé
The rapid structural evolution and emergence of novel synthetic cannabinoid receptor agonists (SCRAs) in the recreational market remains a key public health concern. Despite representing one of the largest classes of new psychoactive substances, pharmacological data on new SCRAs is limited, particularly at the cannabinoid CB
Identifiants
pubmed: 38018694
doi: 10.1002/prp2.1157
pmc: PMC10685394
doi:
Substances chimiques
Cannabinoid Receptor Agonists
0
Receptors, Cannabinoid
0
Ligands
0
Cannabinoids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e01157Subventions
Organisme : Health Research Council of New Zealand
Organisme : University of Otago Doctoral Scholarship
Informations de copyright
© 2023 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.
Références
Pharmacol Biochem Behav. 2022 Oct;220:173467
pubmed: 36154844
ACS Chem Neurosci. 2015 Sep 16;6(9):1546-59
pubmed: 26134475
ACS Chem Neurosci. 2017 Oct 18;8(10):2159-2167
pubmed: 28792725
Nat Chem Biol. 2020 Aug;16(8):841-849
pubmed: 32367019
ACS Chem Neurosci. 2015 Aug 19;6(8):1445-58
pubmed: 25921407
Br J Pharmacol. 2018 May;175(10):1654-1668
pubmed: 29457969
Cell. 2020 Feb 20;180(4):645-654.e13
pubmed: 32004460
Drug Test Anal. 2018 Jan 19;:
pubmed: 29350472
Drug Alcohol Depend. 2014 Nov 1;144:12-41
pubmed: 25220897
Mol Pharmacol. 2016 Jun;89(6):618-29
pubmed: 27009233
Drug Test Anal. 2021 Jul;13(7):1383-1401
pubmed: 33787091
Front Pharmacol. 2019 Apr 10;10:350
pubmed: 31024316
J Anal Toxicol. 2021 Jan 21;44(9):976-984
pubmed: 32091101
Biochem Pharmacol. 2020 May;175:113871
pubmed: 32088263
Drug Test Anal. 2020 Apr;12(4):538-554
pubmed: 31944624
Science. 1999 Dec 24;286(5449):2495-8
pubmed: 10617462
Br J Pharmacol. 2008 Jan;153(2):199-215
pubmed: 17828291
Cell. 2019 Jan 24;176(3):448-458.e12
pubmed: 30639101
Clin Toxicol (Phila). 2018 Jun;56(6):404-411
pubmed: 29072524
Forensic Sci Int. 2016 Apr;261:e5-10
pubmed: 26934903
Front Psychiatry. 2022 Dec 15;13:1048836
pubmed: 36590635
Br J Pharmacol. 2018 Apr;175(7):987-993
pubmed: 29520785
ACS Chem Neurosci. 2022 Apr 20;13(8):1281-1295
pubmed: 35404067
Nat Commun. 2014 Aug 01;5:4589
pubmed: 25081814
Br J Pharmacol. 2010 Jun;160(3):467-79
pubmed: 20590558
Mol Pharmacol. 2016 Nov;90(5):620-626
pubmed: 27338082
Neuropharmacology. 2021 Apr 1;187:108478
pubmed: 33600843
Neuroscience. 1997 Mar;77(2):299-318
pubmed: 9472392
ACS Chem Neurosci. 2016 Sep 21;7(9):1241-54
pubmed: 27421060
Eur Neuropsychopharmacol. 2018 Dec;28(12):1289-1304
pubmed: 30454908
Cell Signal. 2021 Feb;78:109865
pubmed: 33259937
J Pharmacol Exp Ther. 2005 Sep;314(3):1195-201
pubmed: 15917400
ACS Chem Neurosci. 2020 May 20;11(10):1400-1405
pubmed: 32324370
Neuropharmacology. 2021 Aug 1;193:108611
pubmed: 34000272
Int J Drug Policy. 2022 Feb;100:103493
pubmed: 34687992
Drug Test Anal. 2019 Mar;11(3):501-511
pubmed: 30280499
Drug Test Anal. 2021 Jul;13(7):1402-1411
pubmed: 33769699
J Anal Toxicol. 2016 Apr;40(3):236-9
pubmed: 26755539
Forensic Toxicol. 2018;36(2):385-403
pubmed: 29963207
Clin Toxicol (Phila). 2016;54(1):1-13
pubmed: 26567470
Trends Pharmacol Sci. 2022 Sep;43(9):754-771
pubmed: 35906103
Forensic Toxicol. 2019 Jan;37(1):17-26
pubmed: 30705707
ACS Chem Neurosci. 2020 Dec 16;11(24):4434-4446
pubmed: 33253529
J Pharmacol Exp Ther. 2013 Mar;344(3):708-17
pubmed: 23300227
Mol Pharmacol. 2020 Oct;98(4):410-424
pubmed: 32665252
Drug Test Anal. 2021 Feb;13(2):427-438
pubmed: 32997377
Br J Pharmacol. 2019 Dec;176(24):4653-4665
pubmed: 31412133
Nat Commun. 2019 Jan 21;10(1):367
pubmed: 30664663
Front Pharmacol. 2019 May 29;10:595
pubmed: 31191320
J Pharmacol Exp Ther. 2019 Mar;368(3):414-422
pubmed: 30552295
Sci Rep. 2021 May 19;11(1):10611
pubmed: 34012003
Cell. 2020 Feb 20;180(4):655-665.e18
pubmed: 32004463
Br J Pharmacol. 2017 Aug;174(15):2545-2562
pubmed: 28516479
J Anal Toxicol. 2017 Jul 1;41(6):551-558
pubmed: 28637216
EClinicalMedicine. 2020 Jul 24;25:100460
pubmed: 32743487
Pharmacol Biochem Behav. 2020 Jun;193:172918
pubmed: 32247816
RSC Med Chem. 2021 Oct 25;13(2):156-174
pubmed: 35308023
J Pharmacol Exp Ther. 2018 May;365(2):437-446
pubmed: 29549157
Drug Test Anal. 2019 Feb;11(2):279-291
pubmed: 30151911
ACS Chem Neurosci. 2019 Oct 16;10(10):4350-4360
pubmed: 31513380
Drug Test Anal. 2019 Aug;11(8):1183-1191
pubmed: 31021521
Nature. 2016 Sep 8;537(7619):185-190
pubmed: 27533032
Mol Biol Cell. 2017 Nov 15;28(24):3554-3561
pubmed: 28954865
Br J Pharmacol. 2022 May;179(10):2223-2239
pubmed: 34811740
Front Chem. 2019 May 16;7:321
pubmed: 31157203
Forensic Toxicol. 2016;34:329-343
pubmed: 27429655
N Engl J Med. 2017 Jan 19;376(3):235-242
pubmed: 27973993
Drug Test Anal. 2019 Jul;11(7):976-989
pubmed: 30838752
ACS Pharmacol Transl Sci. 2019 Nov 04;3(2):285-295
pubmed: 32296768
J Cell Biol. 2007 Apr 9;177(1):7-11
pubmed: 17420288
Neuropharmacology. 2016 Nov;110(Pt A):143-153
pubmed: 27449567
Sci Signal. 2020 Mar 31;13(625):
pubmed: 32234959
Int J Mol Sci. 2022 Jan 17;23(2):
pubmed: 35055161
Mol Pharmacol. 2014 Mar;85(3):492-509
pubmed: 24366668
Nat Commun. 2017 Jan 03;8:13958
pubmed: 28045021
Br J Pharmacol. 2020 Jul;177(13):2923-2931
pubmed: 32052419
Pharmacol Rev. 2010 Dec;62(4):588-631
pubmed: 21079038
Biochem Pharmacol. 2019 Nov;169:113623
pubmed: 31472128
Toxicol Sci. 2022 Apr 26;187(1):175-185
pubmed: 35201352